Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Commentary

Medical profiteering: the economics of methadone dispensation

Bohdan Nosyk and Aslam H. Anis
CMAJ May 26, 2009 180 (11) 1093-1094; DOI: https://doi.org/10.1503/cmaj.081513
Bohdan Nosyk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aslam H. Anis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • methadone profiteering
    anthony c carr
    Posted on: 01 June 2009
  • Thoughts on alleged methadone "profiteering"
    Robert G. Newman
    Posted on: 29 May 2009
  • Posted on: (1 June 2009)
    Page navigation anchor for methadone profiteering
    methadone profiteering
    • anthony c carr

    The interesting article on "Economics of methadone dispensing" (CMAJ 26 May 09) contains several logical errors, making further discussion difficult.

    It is cheaper to dispense methadone via pharmacies than to in clinics or doctors' offices, but this does NOT mean that "consumer surplus (utility gain) ... are maximized". We could simply execute all opiate addicts - it would be way cheaper! Your writers have fai...

    Show More

    The interesting article on "Economics of methadone dispensing" (CMAJ 26 May 09) contains several logical errors, making further discussion difficult.

    It is cheaper to dispense methadone via pharmacies than to in clinics or doctors' offices, but this does NOT mean that "consumer surplus (utility gain) ... are maximized". We could simply execute all opiate addicts - it would be way cheaper! Your writers have failed to consider the quality-of-life changes: methadone clinics may help the consumer much more than a busy pharmacist.

    The fact that deregulation has led to "a 240% increase in ... patients in [methadone] treatment" does NOT mean that the treatment is working, or that we must "ensure widespread access". It simply means that addicts like procuring free methadone - especially if bribed by pharmacists.

    The reasons that crack cocaine use is more common among "enrolment in a methadone maintenance program" are simple. Methadone clinics are a great place to meet your friendly neighbourhood crack dealer. And clinic doctors are not rigorously refusing to give methadone to patients who continue to abuse other drugs.

    Ethics in Canada are at a low ebb. Even so, it is astonishing to find authors condoning pharmacists who illegally siphon government money into addicts' pockets for them to spend "77% of their income on illicit drugs". Is this really consumer gain?

    Yours, Tony Carr

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
  • Posted on: (29 May 2009)
    Page navigation anchor for Thoughts on alleged methadone "profiteering"
    Thoughts on alleged methadone "profiteering"
    • Robert G. Newman
    TO THE EDITOR: re “Medical profiteering: the economics of methadone dispensation”1, it is difficult to imagine that pharmacists are “paying patients up to $10 a day” when the total dispensing fee they receive is said to be $16.60! Furthermore, the concern that such payments will commonly be used to acquire other drugs seems greatly overstated. After all, compared to even the most generous pharmacy payoffs methadone maintenanc...
    Show More
    TO THE EDITOR: re “Medical profiteering: the economics of methadone dispensation”1, it is difficult to imagine that pharmacists are “paying patients up to $10 a day” when the total dispensing fee they receive is said to be $16.60! Furthermore, the concern that such payments will commonly be used to acquire other drugs seems greatly overstated. After all, compared to even the most generous pharmacy payoffs methadone maintenance itself, to a vastly greater extent, “eliminates the need to purchase illicit heroin”. If such “savings” were merely diverted to purchase of “crack or other illicit drugs” we would not have the consistently reported evidence of the efficacy of this treatment. Robert G. Newman, MD, MPH, Director Baron Edmond de Rothschild Chemical Dependency Institute of Beth Israel Medical Center, NY, NY, USA REFERENCE: 1. Nosyk B and Anis AH. 2009. Medical profiteering: the economics of methadone dispensation. CMAJ. 180(11):1093-94

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 180 (11)
CMAJ
Vol. 180, Issue 11
26 May 2009
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Medical profiteering: the economics of methadone dispensation
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Medical profiteering: the economics of methadone dispensation
Bohdan Nosyk, Aslam H. Anis
CMAJ May 2009, 180 (11) 1093-1094; DOI: 10.1503/cmaj.081513

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Medical profiteering: the economics of methadone dispensation
Bohdan Nosyk, Aslam H. Anis
CMAJ May 2009, 180 (11) 1093-1094; DOI: 10.1503/cmaj.081513
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • Dans ce numéro
  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • How can Canada’s health systems improve care for people with chronic obstructive pulmonary disease?
  • Minimally invasive procedures in gender-affirming care: the case for public funding across Canada
  • Time for Canada to align with global innovations in treatment for tuberculosis
Show more Commentary

Similar Articles

Collections

  • Topics
    • Addiction medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire